BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 21680132)

  • 1. Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium.
    Mhawech-Fauceglia P; Herrmann RF; Kesterson J; Izevbaye I; Lele S; Odunsi K
    Eur J Surg Oncol; 2010 Dec; 36(12):1195-201. PubMed ID: 20926229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.
    Kuwabara Y; Susumu N; Banno K; Hirao T; Kawaguchi M; Yamagami W; Suzuki N; Aoki D; Nozawa S
    Jpn J Clin Oncol; 2005 Jan; 35(1):23-7. PubMed ID: 15681600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in stage II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. P. Mhawech-Fauceglia, R.F. Herrmann, J. Kesterson, I. Izevbaye, S. Lele, K. Odunsi. Eur J Surg Oncol 2010 Dec;36(12):1195-201.
    Geels YP; Massuger LF; Pijnenborg JM
    Eur J Surg Oncol; 2011 Aug; 37(8):734-5; author reply 736. PubMed ID: 21680132
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
    Garg K; Soslow RA
    Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of endometrial carcinoma].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():273-8. PubMed ID: 15535250
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.